Park Avenue Securities LLC Sells 1,331 Shares of The Cooper Companies, Inc. $COO

Park Avenue Securities LLC cut its position in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 17.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 6,260 shares of the medical device company’s stock after selling 1,331 shares during the period. Park Avenue Securities LLC’s holdings in Cooper Companies were worth $445,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in COO. Goldman Sachs Group Inc. boosted its stake in Cooper Companies by 17.0% during the first quarter. Goldman Sachs Group Inc. now owns 4,734,327 shares of the medical device company’s stock valued at $399,340,000 after buying an additional 686,751 shares during the last quarter. Millennium Management LLC boosted its stake in Cooper Companies by 36.0% during the first quarter. Millennium Management LLC now owns 2,577,416 shares of the medical device company’s stock valued at $217,405,000 after buying an additional 682,166 shares during the last quarter. Nuveen LLC bought a new position in Cooper Companies during the first quarter valued at approximately $55,367,000. Alecta Tjanstepension Omsesidigt boosted its stake in Cooper Companies by 60.7% during the second quarter. Alecta Tjanstepension Omsesidigt now owns 1,349,500 shares of the medical device company’s stock valued at $96,030,000 after buying an additional 509,800 shares during the last quarter. Finally, Select Equity Group L.P. boosted its stake in Cooper Companies by 185.0% during the first quarter. Select Equity Group L.P. now owns 749,050 shares of the medical device company’s stock valued at $63,182,000 after buying an additional 486,241 shares during the last quarter. 24.39% of the stock is owned by institutional investors.

Insider Transactions at Cooper Companies

In other news, CEO Albert G. White III acquired 10,000 shares of the company’s stock in a transaction that occurred on Friday, September 5th. The shares were bought at an average price of $68.39 per share, with a total value of $683,900.00. Following the completion of the purchase, the chief executive officer directly owned 226,151 shares in the company, valued at $15,466,466.89. This trade represents a 4.63% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Gerard H. Warner III acquired 1,450 shares of the company’s stock in a transaction that occurred on Friday, September 5th. The stock was purchased at an average cost of $69.23 per share, for a total transaction of $100,383.50. Following the purchase, the chief operating officer owned 18,319 shares of the company’s stock, valued at $1,268,224.37. This represents a 8.60% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last 90 days, insiders bought 17,975 shares of company stock valued at $1,216,346. Company insiders own 1.98% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on COO. Stifel Nicolaus decreased their price objective on Cooper Companies from $90.00 to $85.00 and set a “buy” rating on the stock in a research report on Thursday, August 28th. Morgan Stanley set a $76.00 price objective on Cooper Companies and gave the company an “equal weight” rating in a research report on Thursday, August 28th. JPMorgan Chase & Co. decreased their price objective on Cooper Companies from $76.00 to $66.00 and set a “neutral” rating on the stock in a research report on Thursday, August 28th. Wells Fargo & Company decreased their price objective on Cooper Companies from $93.00 to $72.00 and set an “overweight” rating on the stock in a research report on Thursday, August 28th. Finally, Needham & Company LLC restated a “buy” rating and set a $94.00 price objective on shares of Cooper Companies in a research report on Thursday, August 28th. One analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $86.64.

Cooper Companies Trading Up 0.2%

Shares of NASDAQ COO opened at $67.67 on Tuesday. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12. The business’s 50 day moving average price is $70.06 and its 200-day moving average price is $74.38. The Cooper Companies, Inc. has a fifty-two week low of $61.78 and a fifty-two week high of $110.68. The company has a market cap of $13.45 billion, a price-to-earnings ratio of 33.34, a PEG ratio of 1.77 and a beta of 0.97.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, topping the consensus estimate of $1.07 by $0.03. Cooper Companies had a return on equity of 9.82% and a net margin of 10.08%.The firm had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.06 billion. During the same period in the prior year, the business posted $0.96 earnings per share. The company’s revenue for the quarter was up 5.7% on a year-over-year basis. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. On average, sell-side analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies declared that its Board of Directors has initiated a stock repurchase program on Wednesday, September 17th that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the medical device company to buy up to 15.4% of its shares through open market purchases. Shares repurchase programs are typically an indication that the company’s leadership believes its shares are undervalued.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.